Skip to content
Open access

Multi-omics and experimental validation identify RAPGEF2 as a protective prognostic biomarker in clear cell renal cell carcinoma

Sep 2026 · Translational Oncology · Vol 73 · 0 citations · 45 references
Medicine

TL;DR

Single-cell, spatial transcriptomic and multi-omics analyses reveal endothelial-enriched RAPGEF2 in KIRC and Experimental validation links RAPGEF2 to tumor suppression and immunotherapy benefit.

Abstract

Highlights • Single-cell, spatial transcriptomic and multi-omics analyses reveal endothelial-enriched RAPGEF2 in KIRC.• RAPGEF2 independently predicts favorable survival across multicenter KIRC cohorts.• Experimental validation links RAPGEF2 to tumor suppression and immunotherapy benefit.

Read PDF

Similar papers

Open access Sep 2026

Multi‐Omics Integration Identifies a Five‐Gene Metabolic Signature With Experimental Validation in Clear Cell Renal Cell Carcinoma

Clear cell renal cell carcinoma (ccRCC) is hallmarked by profound metabolic reprogramming; however, its intricate crosstalk with the tumor immune microenvironment (TIME) and its clinical ramifications remain inadequately elucidated. This study aims to systematically decipher the metabolic‐immune interplay in ccRCC thro...

Yi Peng, S. Qin, Xi-Wen Li et al. · 0 citations
Open access Aug 2026

Decoding macrophage-driven tumor heterogeneity in renal cell carcinoma using spatial and single-cell transcriptomics

Highlights • A macrophage-associated prognostic signature was developed for KIRC.• Prognostic genes were identified through Cox analysis and multi-algorithm screening.• An MRCS classifier was independently constructed using SLC11A1 and IFI30.• Survival stratification and validation were systematically performed.

Jing-Jing Duan, Xiang-Lin Liu, Fangmei Zeng et al. · 0 citations
Open access Sep 2026

FABP4 characterizes metabolic–immune interactions and serves as a prognostic biomarker across gynecologic malignancies: a multi-omics integrative analysis

Highlights • FABP4 is broadly downregulated across five gynecologic malignancies.• Promoter hypermethylation is associated with reduced FABP4 expression.• High FABP4 marks poor ovarian/cervical but favorable endometrial outcomes.• Single-cell and spatial data link stromal FABP4 to metabolic–immune crosstalk.• FABP4 kno...

Fang-Fang Chen, Li-Feng Dong, Sai-Sa Zhu et al. · 0 citations
Open access Aug 2026

Lactylation-related immune-metabolic dysregulation defines prognostic and therapeutic stratification in lung adenocarcinoma

Highlights • Single-cell analysis maps lactylation activity across the LUAD ecosystem.• Lactylation-high states show remodeled cell-cell communication networks.• A machine learning-derived LRPS predicts prognosis across cohorts.• Low LRPS is associated with greater immunotherapy benefit.• KRT7 promotes malignant LUAD p...

Meng Wang, Han Zhang, Qiuqiao Mu et al. · 1 citation
Open access Aug 2026

Integrative single-cell and machine-learning analysis identifies LGALS1 as a macrophage-associated diagnostic and prognostic biomarker in hepatocellular carcinoma

Highlights • Single-cell and machine learning defined macrophage-driven LIHC subtypes.• LGALS1 was identified as the top SHAP-ranked therapeutic evasion driver.• LGALS1 was enriched in macrophage and fibroblast lineages in LIHC.• LGALS1 silencing impaired HCC growth, migration, invasion, and clonogenicity.

Yi Wan, Qiang Huo, Yi-Jie Yang et al. · 0 citations
Open access Aug 2026

TCGA-based identification and functional validation of PBK in intrahepatic cholangiocarcinoma progression with involvement of AKT signaling

Highlights • Integrated TCGA analysis via DESeq2, edgeR, limma & WGCNA identified PBK as key ICC gene.• PBK overexpressed in ICC, correlates with tumor stage.• PBK promotes ICC progression via AKT pathway activation; inhibitor abrogates oncogenic effects.• PBK knockdown suppresses xenograft growth with reduced p-AKT, K...

Xiangtian Shi, Lei Zhang, Tengqi Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.